Retroviral vectors for clinical immunogene therapy are stable for up to 9 years. [electronic resource]
Producer: 20080808Description: 268-74 p. digitalISSN:- 1476-5500
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.